Related Experiment Video
Updated: Jun 25, 2026

10:44
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
Published on: November 13, 2017
Efficient hybridoma screening technique using capture antibody based microarrays.
Martin Rieger1, Christian Cervino, Jimena C Sauceda
1Institute of Hydrochemistry, Technische Universität München, Marchioninistrasse 17, 81377 München, Germany.
Analytical Chemistry
|February 14, 2009
Summary
This study introduces an automated antibody microarray method for screening hybridoma cell supernatants. This advanced technique efficiently identifies high-affinity monoclonal antibodies (MAbs) with high accuracy.
Area of Science:
- Biotechnology
- Immunology
- Assay Development
Background:
- Hybridoma screening is critical for generating high-affinity monoclonal antibodies (MAbs), especially for low-molecular weight analytes.
- Current methods can be labor-intensive, necessitating more efficient screening strategies.
Purpose of the Study:
- To develop and validate an advanced, automated antibody microarray screening method for hybridoma cell supernatants.
- To improve the efficiency and accuracy of identifying high-affinity analyte-specific MAbs.
Main Methods:
- Generation of antibody microarrays by contact printing hybridoma cell supernatant samples onto capture antibody-coated glass chips.
- Performance of a noncompetitive immunoassay using an analyte-horseradish peroxidase conjugate.
- Automated chemiluminescence readout system for high-throughput screening.
Main Results:
- The automated microarray method significantly reduces workload compared to standard ELISA screening.
- Data quality is comparable to established microplate-based immunoassay methods.
- Identified three out of four high-affinity MAbs as true positives from 373 samples, with zero false positives.
Conclusions:
- The developed antibody microarray screening method offers an efficient and accurate alternative for MAb generation.
- This automated approach enhances the identification of high-affinity MAbs, particularly for challenging low-molecular weight targets.

